Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anna Fesser1, Marcel Kaiser1, Pascal Mäser1

  • 1Universität Basel Schweizerisches Tropen- und Public Health-Institut (Swiss TPH), Socinstraße 57, CH-4051 Basel, Schweiz.

Biospektrum : Zeitschrift Der Gesellschaft Fur Biologishe Chemie (GBCH) Und Der Vereinigung Fur Allgemeine Und Angewandte Mikrobiologie (VAAM)
|March 29, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Mukavi et al. Antiprotozoal Aminosteroid Alkaloids from <i>Buxus obtusifolia</i> (Mildbr.) Hutch. <i>Molecules</i> 2025, <i>30</i>, 4558.

Molecules (Basel, Switzerland)·2026
Same author

Perovskone, a potential antiprotozoal hit compound, quantification and derivatization.

Scientific reports·2026
Same author

Targeting Kinetoplastid Parasites with ProTide Prodrugs: A Proof-of-Concept Study.

ChemMedChem·2026
Same author

Identification of Steroidal Alkaloids with In Vitro Antiprotozoal Activity from <i>Holarrhena pubescens</i> Wall. ex G. Don.

Molecules (Basel, Switzerland)·2026
Same author

Synthesis of Isobenzofuranones and Isoindolinones via Claisen-Schmidt Condensation and Their Antileishmanial Activity.

ACS omega·2026
Same author

Antiprotozoal Aminosteroid Alkaloids from <i>Buxus obtusifolia</i> (Mildbr.) Hutch.

Molecules (Basel, Switzerland)·2025
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
Same journal

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2023
See all related articles

Chagas disease, caused by Trypanosoma cruzi, requires new treatments, especially for the chronic stage. High-content imaging aids drug discovery by assessing antichagasic potential in cell culture assays.

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Drug Discovery

Context:

  • Chagas disease is a neglected tropical disease caused by the parasite Trypanosoma cruzi.
  • Transmission occurs via triatomine bugs, with global spread due to travel and migration.
  • There is an urgent need for novel therapeutics, particularly for chronic Chagas disease.

Purpose:

  • To highlight the contribution of high-content imaging in Chagas disease research.
  • To demonstrate the utility of fluorescent parasite assays in cell culture.
  • To assess the antichagasic potential of new drug candidates.

Summary:

  • High-content imaging facilitates the study of Trypanosoma cruzi.
  • Fluorescent parasite assays in cell culture enable determination of pharmacodynamic parameters.

Related Experiment Videos

  • This approach aids in evaluating the efficacy of potential new drugs against Chagas disease.
  • Impact:

    • Accelerates the identification and development of new drugs for Chagas disease.
    • Improves the assessment of drug efficacy in preclinical stages.
    • Offers a valuable tool for combating a globally spreading neglected tropical disease.